Nova Biomedical

Waltham, MA, United States

Nova Biomedical

Waltham, MA, United States
SEARCH FILTERS
Time filter
Source Type

In this report, the global Biosensors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosensors in these regions, from 2012 to 2022 (forecast), covering United States EU China Japan South Korea Taiwan For more information or any query mail at sales@wiseguyreports.com Global Biosensors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Abbott Johnson &Johnson Siemens Healthineers Nova Biomedical Bayer ARKRAY Medtronic Roche Sinocare Universal Biosensors On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Wearable Non-Wearable On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosensors for each application, including Medical Environmental Monitoring Food Industry Agriculture Others If you have any special requirements, please let us know and we will offer you the report as you want. Global Biosensors Market Research Report 2017 1 Biosensors Market Overview 1.1 Product Overview and Scope of Biosensors 1.2 Biosensors Segment by Type (Product Category) 1.2.1 Global Biosensors Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Biosensors Production Market Share by Type (Product Category) in 2016 1.2.3 Wearable 1.2.4 Non-Wearable 1.2.4 Type II 1.2.4 Type II 1.3 Global Biosensors Segment by Application 1.3.1 Biosensors Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Medical 1.3.3 Environmental Monitoring 1.3.4 Food Industry 1.3.5 Agriculture 1.3.6 Others 1.4 Global Biosensors Market by Region (2012-2022) 1.4.1 Global Biosensors Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 United States Status and Prospect (2012-2022) 1.4.3 EU Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 South Korea Status and Prospect (2012-2022) 1.4.7 Taiwan Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Biosensors (2012-2022) 1.5.1 Global Biosensors Revenue Status and Outlook (2012-2022) 1.5.2 Global Biosensors Capacity, Production Status and Outlook (2012-2022) 2 Global Biosensors Market Competition by Manufacturers 2.1 Global Biosensors Capacity, Production and Share by Manufacturers (2012-2017) 2.1.1 Global Biosensors Capacity and Share by Manufacturers (2012-2017) 2.1.2 Global Biosensors Production and Share by Manufacturers (2012-2017) 2.2 Global Biosensors Revenue and Share by Manufacturers (2012-2017) 2.3 Global Biosensors Average Price by Manufacturers (2012-2017) 2.4 Manufacturers Biosensors Manufacturing Base Distribution, Sales Area and Product Type 2.5 Biosensors Market Competitive Situation and Trends 2.5.1 Biosensors Market Concentration Rate 2.5.2 Biosensors Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Biosensors Capacity, Production, Revenue (Value) by Region (2012-2017) 3.1 Global Biosensors Capacity and Market Share by Region (2012-2017) 3.2 Global Biosensors Production and Market Share by Region (2012-2017) 3.3 Global Biosensors Revenue (Value) and Market Share by Region (2012-2017) 3.4 Global Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.5 United States Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.6 EU Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.7 China Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.8 Japan Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.9 South Korea Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.10 Taiwan Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 5 Global Biosensors Production, Revenue (Value), Price Trend by Type 5.1 Global Biosensors Production and Market Share by Type (2012-2017) 5.2 Global Biosensors Revenue and Market Share by Type (2012-2017) 5.3 Global Biosensors Price by Type (2012-2017) 5.4 Global Biosensors Production Growth by Type (2012-2017) For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | April 19, 2017
Site: www.PR.com

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. New York, NY, April 19, 2017 --( Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction. The report current values the global biochemistry analyzer market at a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%. Key Research Insights from the Report include: - The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024 - Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patient’s metabolic functions - Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America - Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR - Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to existing product line Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories, Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd., and Nova Biomedical Corp. are profiled in the report as key players of global biochemistry analyzer market. The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers. Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR. The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024. The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted by bench-top biochemistry analyzers. However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues. Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/biochemistry-analyser-market.asp New York, NY, April 19, 2017 --( PR.com )-- In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors. A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction. The report current values the global biochemistry analyzer market at a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.Key Research Insights from the Report include:- The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024- Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patient’s metabolic functions- Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America- Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR- Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to existing product lineRoche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories, Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd., and Nova Biomedical Corp. are profiled in the report as key players of global biochemistry analyzer market.The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers. Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR. The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted by bench-top biochemistry analyzers. However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues.Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/biochemistry-analyser-market.asp Click here to view the list of recent Press Releases from Persistence Market Research


WASHINGTON--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC. In the multicenter study, researchers at three academic medical centers evaluated the trend accuracy of noninvasive, continuous hemoglobin monitoring (SpHb®).1 The prospective observational study was a collaboration among Drs. Richard Applegate and Patricia Applegate of the University of California, Davis; Dr. Maxime Cannesson of the University of California, Los Angeles; and Drs. Prith Peiris, Beth Ladlie, and Klaus Torp of the Mayo Clinic in Jacksonville, Florida. The researchers enrolled 135 adult patients who were scheduled for surgery with planned arterial catheter placement and continuous SpHb monitoring. Each time a blood sample was obtained, the researchers recorded SpHb using a Masimo Radical-7® Pulse CO-Oximeter® with Masimo rainbow® ReSposable R125 sensors (Revision K; same algorithm as Revision L). They also analyzed each blood sample twice to determine clinical laboratory hemoglobin (tHb; Sysmex 550 or Coulter LH 750), arterial blood gas CO-oximeter hemoglobin (ABGHb; Radiometer ABL800, Nova Biomedical CCX or PhOX, or Siemens RAPIDLab 1265), and point-of-care hemoglobin (aHQHb; HemoCue HB 301). To assess overall trend accuracy and trend accuracy within defined ranges, the researchers analyzed the correlation of change in tHb to changes in SpHb, ABGHb, and aHQHb. Trend bias within 10% of tHb was considered clinically equivalent. The researchers found that “The confidence intervals for the proportion of samples with trend bias within 10% of tHb overlapped for SpHb (372 of 416 trends; 89.4%; 86.1% to 92.2%), ABGHb (391 of 416 trends; 94.0%; 91.3 to 95.9%) and aHQHb (406 of 416 trends; 97.6%; 95.6 to 98.7%).” The researchers concluded that “SpHb, ABGHb and aHQHb appear to provide similar intraoperative guidance regarding tHb increase or decrease. Continuous noninvasive SpHb changes larger than ± 0.5 g/dL could provide a reasonable indication for the clinician to obtain a confirmatory blood sample for Hb measurement, but not replace such measurement in guiding transfusion decision making. The transfusion impact of continuous hemoglobin trend monitoring should be studied.” SpHb monitoring may provide additional insight to the directional trend of hemoglobin between invasive blood samplings – when the SpHb trend is stable and the clinician may otherwise think hemoglobin is decreasing; when the SpHb trend is rising and the clinician may otherwise think hemoglobin is not rising fast enough; or when the SpHb trend is decreasing and the clinician may otherwise think hemoglobin is stable. Clinical decisions regarding red blood cell transfusions should be based on the clinician’s judgment considering, among other factors: patient condition, continuous SpHb monitoring, and laboratory diagnostic tests using blood samples. The study was supported by research grants from Masimo to Loma Linda University, Mayo Clinic in Florida, and the University of California, Irvine. Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,1 improve CCHD screening in newborns,2 and, when used for continuous monitoring with Masimo Patient SafetyNet™* in post-surgical wards, reduce rapid response activations and costs.3,4,5 Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world,6 including 17 of the top 20 hospitals listed in the 2016-17 U.S. News and World Report Best Hospitals Honor Roll.7 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more recently, Pleth Variability Index (PVi®) and Oxygen Reserve Index (ORi™), in addition to SpO , pulse rate, and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect™ (MOC-9™) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7™ wearable patient monitor, iSpO ® pulse oximeter for smartphones, and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at http://www.masimo.com/cpub/clinical-evidence.htm. *The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium. This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo Rad-G™. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo SpHb®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo SpHb, contribute to positive clinical outcomes and patient safety; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.


Browse 180 Tables and Figures, 15 Companies, spread across 116 pages available at http://www.reportsnreports.com/reports/975744-global-sterilization-trays-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html. In the start report describe Sterilization Trays Introduction, product scope, market overview, market opportunities, market risk and growth driving force. The report further analyze the top manufacturers of Sterilization Trays, with sales, revenue, and price of Sterilization Trays, in 2016 and 2017. It display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017. The report then show the global market by regions, with sales, revenue and market share of Sterilization Trays, for each region, from 2012 to 2017. It analyze the key regions, with sales, revenue and market share by key countries in these regions. The report has analysed the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017. The report also forecast the Sterilization Trays market by regions, type and application, with sales and revenue, from 2017 to 2022. In the end the report describe Sterilization Trays sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source. Market Segment by Manufacturers, this report covers are Medline, Placon, Terumo, Keir Surgical, Solvay, PST Corp, Aesculap, Pyxidis, Summit Medical, Ethicon, Key Surgical, Volk Optical, Aygun, WPI, Sklar. Market Segment by Regions, regional analysis covers are North America (USA, Canada and Mexico); Europe (Germany, France, UK, Russia and Italy); Asia-Pacific (China, Japan, Korea, India and Southeast Asia); South America (Brazil, Argentina, Columbia etc.) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers are Stainless Steel Trays, Plastic Trays and Others Market Segment by Applications, can be divided into Hospital, Clinic, Laboratory and Other Global Glucose Meter Market by Manufacturers, Countries, Type and Application, Forecast to 2022: Companies profiled are Roche, JNJ, Bayer, Abbott, Omron, Arkray, Grace, B.Braun, I-SENS, Inc, Infopia Co., Ltd, Hainice Medical Inc, Mendor, All Medicus Co., Ltd, 77 Elektronika Müszeripari Kft, Delta Group, Ok Biotech, Medisana, FIFTY50(USA), Nova Biomedical(USA), Oak Tree Tree Health, Inc.(USA), Omnis Health(USA), Simple Diagnostics(USA), US Diagnostics(USA), SD Biosensor, INC(Korea), Nipro, Terumo Corporation, Homemed (Pty) Ltd(South Africa), Sannuo, Yuwell Medical and YICHENG Global Jaundice Meter Market by Manufacturers, Countries, Type and Application, Forecast to 2022: The report analyses the market by Type (Portable and Bench-top) and by Applications (Hospital and Home). Companies profiled are Drger, Delta Medical International, Xuzhou Kejian Hi-tech, Aegis Medicals, Natus Medical, Refine Medical Technology, M&B, Micro Lab Global Hearing Healthcare Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2022: The Companies profiled in the global Hearing Healthcare Devices market are William Demant, Sonova, GN Store Nord, Sivantos Group, Widex, Starkey, Cochlear, MED-EL GmbH, Natus Medical Explore more reports on Medical Devices at http://www.reportsnreports.com/market-research/medical-devices/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


This report, Top 50 Companies in Point-of-Care Diagnostic Testing, profiles the following companies based on their size, product range, innovative capacity and influence in the market: Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC).   The market is large and companies of various sizes are involved in the development and/or marketing of POC testing. The market is considered evolving with growth opportunity. Developing and developed markets alike have room to grow due to an aging population worldwide. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. In addition to profiles of these companies and recent revenue performance where financial information is available, the report provides market sizing and share for the entire POC test market. It also provides market data, including: - Alere - Abbott, Danaher Cepheid and Other Industry Developments - Size and Growth of the Point-of-Care Diagnostics Market, 2016-2021 - Market by Test Segment (Glucose, Pregnancy, FOB, Infectious Disease, Coagulation, Other) - Market by Self-Testing or Professional Testing - Market Share by Vendor - Company Profiling and Revenue Performance - Trends in the Industry Key Topics Covered: 1: Executive Summary - Introduction - Scope and Methodology - Size and Growth Of The Point-Of-Care Market - Trend - Alere and Abbott Merger - Trend - "Star Trek" POC Devices - Trend - Danaher Buys Cepheid - Trend - Retail Clinics - Companies In The POC Market 2: Top 50 Point Of Care Diagnostic Companies - Corporate Profiles - Abaxis, Inc. - Abbott Laboratories - Accriva Diagnostics - Accubiotech Co, Ltd. - Acon Laboratories, Inc - Alere Inc - Arkray - Atlas Genetics Ltd. - Atlas Link Biotech Co., Ltd. - Beckman Coulter, Inc. - Church & Dwight Co. Inc - Danaher Corporation - Dexcom, Inc - Dragerwerk Ag & Co.  - Eiken Chemical Co Ltd. - EKF Diagnostics - Enigma Diagnostics, Ltd. - Enterix, Inc - Exact Sciences - Helena Laboratories - Menarini Diagnostics - Meridian Bioscience, Inc - Micronics, Inc - Nova Biomedical, Corp. - Opko Health, Inc - Orasure Technologies, Inc. - Ortho Clinical Diagnostics - Polymer Technologies, Inc (Pts Diagnostics) - Roche Diagnostic Corporation - Samsung Healthcare - Sekisui Diagnostics - Siemens Healthineers - Sysmex Corporation - Trinity Biotech  - Veredus Laboratories  Ltd 3: POC Testing Market Share And Market Analysis For more information about this report visit http://www.researchandmarkets.com/research/9r93k4/top_50_companies Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/top-50-companies-in-point-of-care-diagnostic-testing-2017-with-size-and-growth-of-the-point-of-care-diagnostics-market-2016-2021---research-and-markets-300462487.html


Browse 180 Tables and Figures, 15 Companies, spread across 116 pages available at http://www.reportsnreports.com/reports/975744-global-sterilization-trays-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html. In the start report describe Sterilization Trays Introduction, product scope, market overview, market opportunities, market risk and growth driving force. The report further analyze the top manufacturers of Sterilization Trays, with sales, revenue, and price of Sterilization Trays, in 2016 and 2017. It display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017. The report then show the global market by regions, with sales, revenue and market share of Sterilization Trays, for each region, from 2012 to 2017. It analyze the key regions, with sales, revenue and market share by key countries in these regions. The report has analysed the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017. The report also forecast the Sterilization Trays market by regions, type and application, with sales and revenue, from 2017 to 2022. In the end the report describe Sterilization Trays sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source. Market Segment by Manufacturers, this report covers are Medline, Placon, Terumo, Keir Surgical, Solvay, PST Corp, Aesculap, Pyxidis, Summit Medical, Ethicon, Key Surgical, Volk Optical, Aygun, WPI, Sklar. Market Segment by Regions, regional analysis covers are North America (USA, Canada and Mexico); Europe (Germany, France, UK, Russia and Italy); Asia-Pacific (China, Japan, Korea, India and Southeast Asia); South America (Brazil, Argentina, Columbia etc.) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers are Stainless Steel Trays, Plastic Trays and Others Market Segment by Applications, can be divided into Hospital, Clinic, Laboratory and Other Global Glucose Meter Market by Manufacturers, Countries, Type and Application, Forecast to 2022: Companies profiled are Roche, JNJ, Bayer, Abbott, Omron, Arkray, Grace, B.Braun, I-SENS, Inc, Infopia Co., Ltd, Hainice Medical Inc, Mendor, All Medicus Co., Ltd, 77 Elektronika Müszeripari Kft, Delta Group, Ok Biotech, Medisana, FIFTY50(USA), Nova Biomedical(USA), Oak Tree Tree Health, Inc.(USA), Omnis Health(USA), Simple Diagnostics(USA), US Diagnostics(USA), SD Biosensor, INC(Korea), Nipro, Terumo Corporation, Homemed (Pty) Ltd(South Africa), Sannuo, Yuwell Medical and YICHENG Global Jaundice Meter Market by Manufacturers, Countries, Type and Application, Forecast to 2022: The report analyses the market by Type (Portable and Bench-top) and by Applications (Hospital and Home). Companies profiled are Drger, Delta Medical International, Xuzhou Kejian Hi-tech, Aegis Medicals, Natus Medical, Refine Medical Technology, M&B, Micro Lab Global Hearing Healthcare Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2022: The Companies profiled in the global Hearing Healthcare Devices market are William Demant, Sonova, GN Store Nord, Sivantos Group, Widex, Starkey, Cochlear, MED-EL GmbH, Natus Medical Explore more reports on Medical Devices at http://www.reportsnreports.com/market-research/medical-devices/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Loading Nova Biomedical collaborators
Loading Nova Biomedical collaborators